Your browser doesn't support javascript.
loading
Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib.
Crona, Daniel J; Skol, Andrew D; Leppänen, Veli-Matti; Glubb, Dylan M; Etheridge, Amy S; Hilliard, Eleanor; Peña, Carol E; Peterson, Yuri K; Klauber-DeMore, Nancy; Alitalo, Kari K; Innocenti, Federico.
Afiliação
  • Crona DJ; Division of Pharmacotherapy and Experimental Therapeutics, Center for Pharmacogenomics and Individualized Therapy, The University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina.
  • Skol AD; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
  • Leppänen VM; The University of Chicago, Department of Medicine, Chicago, Illinois.
  • Glubb DM; Wihuri Research Institute and University of Helsinki, Helsinki, Finland.
  • Etheridge AS; Division of Pharmacotherapy and Experimental Therapeutics, Center for Pharmacogenomics and Individualized Therapy, The University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina.
  • Hilliard E; The Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Peña CE; Division of Pharmacotherapy and Experimental Therapeutics, Center for Pharmacogenomics and Individualized Therapy, The University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina.
  • Peterson YK; Department of Surgery, Medical University of South Carolina, Charleston, South Carolina.
  • Klauber-DeMore N; Bayer HealthCare Pharmaceuticals, Montville, New Jersey.
  • Alitalo KK; Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina.
  • Innocenti F; Department of Surgery, Medical University of South Carolina, Charleston, South Carolina.
Cancer Res ; 79(1): 231-241, 2019 01 01.
Article em En | MEDLINE | ID: mdl-30385613
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Regulação Neoplásica da Expressão Gênica / Receptor 3 de Fatores de Crescimento do Endotélio Vascular / Fator A de Crescimento do Endotélio Vascular / Sorafenibe / Neoplasias Renais / Mutação Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Regulação Neoplásica da Expressão Gênica / Receptor 3 de Fatores de Crescimento do Endotélio Vascular / Fator A de Crescimento do Endotélio Vascular / Sorafenibe / Neoplasias Renais / Mutação Idioma: En Ano de publicação: 2019 Tipo de documento: Article